YD Bio (NASDAQ:YDES) Trading Down 1.4% – Time to Sell?

Posted by Francis Steltz on May 22nd, 2026

YD Bio Limited (NASDAQ:YDES – Get Free Report) traded down 1.4% during mid-day trading on Tuesday . The stock traded as low as $4.54 and last traded at $4.99. 8,277 shares were traded during trading, an increase of 10% from the average session volume of 7,517 shares. The stock had previously closed at $5.06.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen upgraded shares of YD Bio from a “sell” rating to a “hold” rating in a report on Saturday, February 28th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, YD Bio presently has a consensus rating of “Sell”.

View Our Latest Research Report on YD Bio

YD Bio Stock Performance

The stock has a fifty day moving average price of $6.06.

Institutional Investors Weigh In On YD Bio

An institutional investor recently raised its position in YD Bio stock. Geode Capital Management LLC boosted its holdings in YD Bio Limited (NASDAQ:YDES – Free Report) by 10.0% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 58,363 shares of the biotechnology company’s stock after purchasing an additional 5,292 shares during the quarter. Geode Capital Management LLC owned about 0.08% of YD Bio worth $711,000 at the end of the most recent quarter.